NCT04198961 - Electronic Intervention to Chronic Opioid Therapy | Crick | Crick

Electronic Intervention to Chronic Opioid Therapy

N/ACompletedNCT04198961

Stanford University43 enrolled

Overview

This pilot study will attempt to apply an electronic chart intervention to improve safety for patients on chronic opioid medications.

Study Type

INTERVENTIONAL

Allocation

NA

Purpose

OTHER

Masking

NONE

Enrollment

43

Conditions

Chronic Opioid Therapy

Interventions

opioid prescribingOTHER

Individualized taper and safety recommendations will be communicated to prescribers via an electronic medical record encrypted message.

Eligibility

Sex: ALLMin age: 18 YearsMax age: 65 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Patients prescribed long-term opioid therapy of doses greater than 90 morphine equivalent daily dose (MEDD) Exclusion Criteria: * Patients prescribed short-term opioid medications for acute pain (less than a 90-day supply over the past 120 days), sublingual buprenorphine, methadone maintenance for opioid use disorder or with oncology or palliative care diagnoses will be excluded.

Locations (1)

Stanford University

Stanford, California, United States

Outcomes

Primary Outcomes

Change in the number of patients who receives naloxone prescription

Change in the number of patients who receives naloxone prescription

Time frame: baseline, 1, 3- and 6-months and 12 months

change of number of documentation about safety discussions

change of number of documentation about safety discussions

Time frame: baseline, 1, 3- and 6-months and 12 months

change of number of order for urine toxicology screening

change of number of order for urine toxicology screening

Time frame: baseline, 1, 3- and 6-months and 12 months

change of number of documentation of prescription drug monitoring program (CURES) results

change of number of documentation of prescription drug monitoring program (CURES) results

Time frame: baseline, 1, 3- and 6-months and 12 months

change of number of signed opioid informed consent forms

change of number of signed opioid informed consent forms

Time frame: baseline, 1, 3- and 6-months and 12 months

Secondary Outcomes

Change in number of patients on long-term high risk doses of opioid pain medications

decreases in daily dose of opioids and number of patients on opioids ≥ 90mg MEDD

Time frame: baseline, 1, 3- and 6-months and 12 months

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.